Correlation Between Qingdao Haier and China Molybdenum

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Qingdao Haier and China Molybdenum at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Qingdao Haier and China Molybdenum into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Qingdao Haier Biomedical and China Molybdenum Co, you can compare the effects of market volatilities on Qingdao Haier and China Molybdenum and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Qingdao Haier with a short position of China Molybdenum. Check out your portfolio center. Please also check ongoing floating volatility patterns of Qingdao Haier and China Molybdenum.

Diversification Opportunities for Qingdao Haier and China Molybdenum

0.55
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Qingdao and China is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Qingdao Haier Biomedical and China Molybdenum Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on China Molybdenum and Qingdao Haier is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Qingdao Haier Biomedical are associated (or correlated) with China Molybdenum. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of China Molybdenum has no effect on the direction of Qingdao Haier i.e., Qingdao Haier and China Molybdenum go up and down completely randomly.

Pair Corralation between Qingdao Haier and China Molybdenum

Assuming the 90 days trading horizon Qingdao Haier Biomedical is expected to generate 1.37 times more return on investment than China Molybdenum. However, Qingdao Haier is 1.37 times more volatile than China Molybdenum Co. It trades about -0.01 of its potential returns per unit of risk. China Molybdenum Co is currently generating about -0.02 per unit of risk. If you would invest  3,792  in Qingdao Haier Biomedical on September 1, 2024 and sell it today you would lose (464.00) from holding Qingdao Haier Biomedical or give up 12.24% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy99.19%
ValuesDaily Returns

Qingdao Haier Biomedical  vs.  China Molybdenum Co

 Performance 
       Timeline  
Qingdao Haier Biomedical 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Qingdao Haier Biomedical are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Qingdao Haier sustained solid returns over the last few months and may actually be approaching a breakup point.
China Molybdenum 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days China Molybdenum Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, China Molybdenum is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Qingdao Haier and China Molybdenum Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Qingdao Haier and China Molybdenum

The main advantage of trading using opposite Qingdao Haier and China Molybdenum positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Qingdao Haier position performs unexpectedly, China Molybdenum can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China Molybdenum will offset losses from the drop in China Molybdenum's long position.
The idea behind Qingdao Haier Biomedical and China Molybdenum Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation